Shang­hai biotech’s VEGF bis­pe­cif­ic en­ters Phase 1 tri­al in Chi­na

6 months ago
Financing
R&D

Gilead pulls Trodelvy's ac­cel­er­at­ed la­bel in blad­der can­cer af­ter drug failed con­fir­ma­to­ry study

6 months ago
R&D
Pharma

Con­sumer and union groups call on FTC to ‘chal­lenge’ No­vo-Catal­ent deal

6 months ago
Deals
Pharma

Pfiz­er ends tri­al of Ar­ray-ac­quired SHP2 in­hibitor af­ter sim­i­lar cuts from peers

6 months ago
R&D
Pharma

CVS re­places CEO Karen Lynch with PBM ex­ec David Joyn­er

6 months ago
People
Health Tech

Su­per­nus’ de­pres­sion drug shows ‘rapid’ on­set in mid-stage test

6 months ago
R&D

Ex­clu­sive: Ex-Af­fimed CEO heads to UK nanomed­i­cine biotech; Ja­mi Ru­bin leaves Bound­less Bio af­ter IPO

6 months ago
Peer Review

Mer­ck un­veils RSV an­ti­body da­ta, in bid to com­pete with As­traZeneca and Sanofi

6 months ago
R&D
Pharma

Pfiz­er’s RSV vac­cine has 90% ef­fi­ca­cy against se­vere res­pi­ra­to­ry dis­ease

6 months ago
Pharma

Am­i­cus stock jumps af­ter res­o­lu­tion of Galafold patent lit­i­ga­tion against Te­va

6 months ago
Pharma
Law

In­ter­cep­t's liv­er dis­ease drug faces full ap­proval de­lay fol­low­ing neg­a­tive ad­comm

6 months ago
Pharma
FDA+

Amy­lyx presents full Phase 2 da­ta for with­drawn ALS drug in an­oth­er rare ge­net­ic dis­ease

6 months ago
R&D

Se­cre­tive Tree­line Bio­sciences dis­clos­es $421M fi­nanc­ing in fil­ing

6 months ago
Financing
Startups

House’s promi­nent Chi­na crit­ic Jim Mc­Gov­ern leads op­po­si­tion to Biose­cure Act: ‘I would pre­fer to go back to the ...

6 months ago
China
Manufacturing

FDA fi­nal­izes guid­ance on gener­ic drugs, can­cer tri­als and neona­tal drug de­vel­op­ment

6 months ago
FDA+

FDA de­lays col­orec­tal can­cer de­ci­sion for Am­gen's Lumakras, a set­back in race with Bris­tol My­ers

6 months ago
Pharma
FDA+

RNA gene ther­a­py start­up Shape hunts for new CEO as Se­ries C awaits

6 months ago
People
Startups

Evonik winds down Ger­man site, lays off 260 work­ers; Chiesi’s €400M fa­cil­i­ty

6 months ago
Manufacturing

Mer­ck KGaA eyes more man­u­fac­tur­ing M&A as it faces head­winds in Chi­na

6 months ago
China
Manufacturing

Benev­o­len­tAI CEO is out af­ter less than a year on the job

6 months ago
People
AI

FDA ex­pands la­bel for Avadel's nar­colep­sy drug in­to chil­dren

6 months ago
Pharma
FDA+

Vi­a­tris, Lex­i­con ink li­cens­ing deal; Capri­cor’s $75M of­fer­ing

6 months ago
News Briefing

FDA ap­proves Ab­b­Vie's 24-hour Parkin­son's in­fu­sion ther­a­py af­ter two CRLs

6 months ago
Pharma
FDA+

Ei­sai to ask Aus­tralia to re­con­sid­er re­jec­tion of Alzheimer's drug Leqem­bi

6 months ago
Pharma
First page Previous page 79808182838485 Next page Last page
A service from the Financial Times